M. Balaji
Research Subjects
M. Balaji has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- A. Gopalan
Department of Civil Engineering, Erode Sengunthar Engineering College, Perundurai, Erode 638057, India
1 shared publication - B. Anukarthika
Department of Civil Engineering, Erode Sengunthar Engineering College, Perundurai, Erode 638057, India
1 shared publication - G. Shanmugavadivel
Department of Electronics and Communication Engineering, M.Kumarasamy College of Engineering, Karur 639113, India
1 shared publication - J. Arun Prasad
Erode Sengunthar Engineering College
1 shared publication - N. R. Banu Priya
Department of Civil Engineering, Dhanalakshmi Srinivasan Institute of Technology, Samayapuram 621112, India
1 shared publication - Nyagong Santino David Ladu
Department of Mathematics and Physics, Rumbek University of Science and Technology, Rumbek, South Sudan
1 shared publication
Latest Publications
- Open Access
- 21 August 2022
- Published by Wiley in Advances in Materials Science and Engineering
- Vol. 2022, 1-6
Pharmaceutical Effluent Treatment Using Multi-effect Evaporator Process
The disposal practices of pharmaceutical-generated pollutants have become a serious threat to mankind’s health, safety, and environmental concerns. Pharmaceutically polluted effluents have been demonstrated as endocrine disruptors which mimic growth hormones when consumed at nG/L to mG/L concentrations. The production stages utilize both organic and inorganic compounds, which contribute to chemical oxygen demand (COD) and total dissolved solids (TDS) heavily. Conventional technologies have failed to accomplish zero liquid minimization. To achieve zero minimization, it is necessary to develop modernization techniques in effluent treatment streams. A novel technique to recover solids and organic matter removals as well as zero-liquid discharge (ZLD) flash mixer, stripping, and multi-effect evaporator (MEE) processes is employed. Flash mixing is a pre-treatment stage, and stripping enables solvent reclamation. The multi-effect evaporators involve heat transfer equipment mainly used for volume reduction and cutting down on waste handling costs. The multi-effect evaporator not only is able to eliminate pharmaceutical xenobiotics but also requires pre-treatments such as flash mixture and stripping column sections. Thus, this research emphasizes efficiently removing high total dissolved solids (HTDS) and high chemical oxygen demand (HCOD) from pharmaceutical effluent. The removal efficiency was found to be 85% for TDS and TSS, 93% for BOD, and 81% for COD, which is more than the conventional mode of treatment.
- 21 August 2022
- Published by Wiley in Advances in Materials Science and Engineering
- Vol. 2022, 1-6
Open AccessPharmaceutical Effluent Treatment Using Multi-effect Evaporator Process
The disposal practices of pharmaceutical-generated pollutants have become a serious threat to mankind’s health, safety, and environmental concerns. Pharmaceutically polluted effluents have been demonstrated as endocrine disruptors which mimic growth hormones when consumed at nG/L to mG/L concentrations. The production stages utilize both organic and inorganic compounds, which contribute to chemical oxygen demand (COD) and total dissolved solids (TDS) heavily. Conventional technologies have failed to accomplish zero liquid minimization. To achieve zero minimization, it is necessary to develop modernization techniques in effluent treatment streams. A novel technique to recover solids and organic matter removals as well as zero-liquid discharge (ZLD) flash mixer, stripping, and multi-effect evaporator (MEE) processes is employed. Flash mixing is a pre-treatment stage, and stripping enables solvent reclamation. The multi-effect evaporators involve heat transfer equipment mainly used for volume reduction and cutting down on waste handling costs. The multi-effect evaporator not only is able to eliminate pharmaceutical xenobiotics but also requires pre-treatments such as flash mixture and stripping column sections. Thus, this research emphasizes efficiently removing high total dissolved solids (HTDS) and high chemical oxygen demand (HCOD) from pharmaceutical effluent. The removal efficiency was found to be 85% for TDS and TSS, 93% for BOD, and 81% for COD, which is more than the conventional mode of treatment.